Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Piperacillin sodium 4g/vial injection (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Piperacillin sodium |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Piperacillin sodium 3g powder for injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Piperacillin sodium |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely piperacillin (as piperacillin sodium) 3 gram and tazobactam (as tazobactam sodium) 375 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Piperacillin sodium |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Piperacillin 40g injection (pdr for recon) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Piperacillin sodium |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Piperacillin 1g injection (pdr for recon) (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Piperacillin sodium |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
pipéracilline 2 g, fiole de poudre pour solution injectable |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Piperacillin sodium |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Piperacillin 4g infusion (pdr for recon) (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Piperacillin sodium |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Piperacillin (as piperacillin sodium) 2 g and tazobactam (as tazobactam sodium) 250 mg powder for solution for injection vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Piperacillin sodium |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
pipéracilline 4 g/tazobactam 500 mg, fiole de poudre et solvant pour perfusion |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Piperacillin sodium |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely piperacillin (as piperacillin sodium) 4 gram and tazobactam (as tazobactam sodium) 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Piperacillin sodium |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing piperacillin and tazobactam (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Piperacillin sodium |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Piperacillin+tazobactam 36g/4.5g injection (pdr for recon) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Piperacillin sodium |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Piperacillin (as piperacillin sodium) 2 g and tazobactam (as tazobactam sodium) 250 mg powder for solution for injection vial |
Has precise active ingredient |
False |
Piperacillin sodium |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely piperacillin (as piperacillin sodium) 4 gram and tazobactam (as tazobactam sodium) 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has precise active ingredient |
True |
Piperacillin sodium |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Piperacillin anhydrous (as piperacillin sodium) 4 g powder for solution for injection vial |
Has precise active ingredient |
True |
Piperacillin sodium |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Piperacillin anhydrous (as piperacillin sodium) 3 g powder for solution for injection vial |
Has precise active ingredient |
True |
Piperacillin sodium |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely piperacillin anhydrous (as piperacillin sodium) 2 gram/1 vial powder for conventional release solution for injection (clinical drug) |
Has precise active ingredient |
True |
Piperacillin sodium |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely piperacillin anhydrous (as piperacillin sodium) 1 gram/1 vial powder for conventional release solution for injection (clinical drug) |
Has precise active ingredient |
True |
Piperacillin sodium |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely piperacillin (as piperacillin sodium) 3 gram and tazobactam (as tazobactam sodium) 375 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
Has precise active ingredient |
True |
Piperacillin sodium |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Piperacillin (as piperacillin sodium) 2 g and tazobactam (as tazobactam sodium) 250 mg powder for solution for injection vial |
Has precise active ingredient |
True |
Piperacillin sodium |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely piperacillin (as piperacillin sodium) 4 gram and tazobactam (as tazobactam sodium) 500 milligram/1 vial powder for conventional release solution for infusion (clinical drug) |
Has precise active ingredient |
True |
Piperacillin sodium |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely piperacillin (as piperacillin sodium) 2 gram and tazobactam (as tazobactam sodium) 250 milligram/1 vial powder for conventional release solution for infusion (clinical drug) |
Has precise active ingredient |
True |
Piperacillin sodium |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely piperacillin (as piperacillin sodium) 2 gram and tazobactam (as tazobactam sodium) 250 milligram/1 vial powder for conventional release solution for infusion and/or injection (clinical drug) |
Has precise active ingredient |
True |
Piperacillin sodium |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Piperacillin (as piperacillin sodium) 4 g and tazobactam (as tazobactam sodium) 500 mg powder for solution for infusion and/or injection vial |
Has precise active ingredient |
True |
Piperacillin sodium |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |